If, some months ago, I had been been asked which were the main candidates for the doubtful honour of being human cancer virus, I would have mentioned Epstein-Barr virus and, after a pause, Awould have speculated concerning the role of some of the retro viruses which have been recovered from primate tissues. And yet, almost surreptitiously, evidence has been accumulating for the role of the hepatitis B virus as a cause of primary hepatocellular carcinoma, itself one of the most wNidespread cancers in many parts of the world. This volume comprises the proceedings of a wrorkshop held in Senegal early last year. In China, South Africa and West Africa, the incidence of primary liver cancer is up to 150 cases per 100,000 of the population. These areas are also areas of a high hepatitis B prevalence, and it is no surprise therefore that several of the papers in this symposium stem from Senegal; these wAere epidemiological in nature and included interesting reports of immunisation programmes in this area of high endemicity. Other reports cover the role of alcoholism (in France) and epidemiological surveys in Greece, America and Taiwan. The detection of hepatitis B antigens in hepatocellular carcinoma, using immunofluorescence, is described in reports from Poland and France. In an interesting paper from the Institut Pasteur, hepatitis B virus DNA sequences were detected in extracts of human hepatocellular carcinoma wAThich were digested wiith restriction enzymes and transferred to nitrocellulose filters by the Southern Blotting technique. Usiiig cloned hepatitis B virus DNA as a probe, hybridization indicated that hepatitis B virus DNA sequences had been integrated into the lhuman tumour tissues and into a hepatoma cell line. In another report, hepatitis A virus wTas propagated in cell lines derived from primary human hepatocellular carcinomas.
Two short revieAw articles describe cancers associated with viruses in man and animals and compare feline leukaemia virus and hepatitis B virus infections. Brief details of the large-scale production in Japan of hepatitis B vaccine, using high-titred plasma are described Of perhaps greater importance for the future, is the description of the production of hepatitis B virus surface antigen in Escherichia coli.
This volume is one of the well-known series "Progress in Medical Virology", individual volumes of wihich form succinct and useful items in a series of reviews of the growNNing points of virology. This volume is no exception to the uniformly high standard of the series, and can be confidently recommended as a conspectus of this particular area. The cost would probably prevent it being purchased by individuals, but it should find its place on the shelves of libraries concerned with virology, infectious diseases and oncology.
R This is the third of a 4-volume set dealing wNith the application of electron microscopy to the field of diagnostic medicine. One immediately appreciates in it the same high standard of presentation apparent in Vols 1 & 2. The intellectual content is also more than commensurate with the high level of technical presentation; all contributions are liberally and economically illustrated with high-quality light and electron micrographs. There is a heavy emphasis on tumoral aspects: the chapter on micro-organisms, the account of renal disease and the contribution on skin, provide some measure of balance in terms of general histopathology.
The volume opens with a chapter by Burns on "Micro-organisms". The title rnight have merited a fuller illustrative treatment of diagnostic virology and bacteriology using negative staining, and pathogenic amoebae and leishmania, although uncom- Churg, Spargo, Sakaguchi & Jones' detailed appraisal of one of the earliest and most important areas of application ("Diagnostic Electron Microscopy of Renal Disease") is a substantial account of over 100 pages and is lavishly illustrated (most illustrations being of full-page size). It will be essential reading for any histopathologist encountering renal material, though, despite its title, the chapter omits neoplastic conditions of the kidney. Wood & Hu's "Diagnostic Electron Microscopy of the Skin", covers neoplastic and non-neoplastic conditions. This is an excellent treatment of the subject, with some exceptionally fine illustrations. The volume culminates in a comprehensive treatment by Bloodworth, Horvath & Kovacs on the "Fine Structural Pathology of the Endocrine System". This chapter, in keeping intellectually and presentationally with the rest of the volume, must be considered a significant contribution to this field.
"Diagnostic Electron Microscopy volume 3", in summary, will provide histopathologists with access to or an interest in electron microscopy with authoritative treatments of several major areas of tumour and nontumour application: it will be particularly welcomed by those specializing in neoplasia. The price of over £50 cannot be considered high for such a quality volume of over 500 pages.
B This sort of book should not be published. It is the proceedings of a symposium held in Paris in December, 1979 and had reached the bookshops in 1981 at the exhorbitant price of £39.50. The papers were all by invited speakers (9 from France; 2 from Belgium; 2 from U.S.A.; one each from U.K. and Switzerland) and, whilst some of the work described was recent or in progress, many of the "frontiers" being reviewed were passed well before the conference took place. Indeed in some sections, e.g. those on "The Natural History of Benign Breast Tumours" and on "Cystosarcoma phyllodes", there are no new ideas or observations at all, merely pedestrian accounts which would scarcely be adequate in a standard text book.
There There has been an enormous expansion of cancer literature in recent decades as a result of the large number of clinical trials and other studies carried out throughout the world. Comparisons of the results of such studies are often made difficult because of the lack of a "common language". This WHO handbook (and an article in Cancer, 47, 207, 1981) arose from 2 meetings of international experts from many disciplines, and sets out some generally acceptable principles for evaluating data and reporting results. The first chapter deals with the minimum amount of data that should be recorded as regards patient characteristics, the tumour, and laboratory and radiological investigations. The next chapter deals with describing treatment details and here the committee suggests the term "adjuvant therapy" should not be used since what is considered adjuvant to primary treatment today may become primary treatment tomorrow. Instead "combined modality therapy" is recommended.
Other chapters cover the grading of toxic effects and response: the definitions recommended are those which have been in general use for the last few years. In many trials first recurrence is an important end-point, but determining the date on which it occurred can be difficult: the committee recommends
